The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients
Anastasiou M, Oikonomou E, Theofilis P, Papamikroulis G, Gazouli M, Pesiridis T, Goliopoulou A, Papatheodoridi D, Psyrri A, Zagouri F, Siasos G, Tousoulis D. The effect of anthracycline-based chemotherapy on endothelial function and arterial stiffness in breast cancer patients. European Heart Journal 2023, 44: ehad655.2675. DOI: 10.1093/eurheartj/ehad655.2675.Peer-Reviewed Original ResearchFlow-mediated dilatationPulse wave velocityAnthracycline-based chemotherapyBreast cancer patientsBreast cancerEndothelial functionArterial stiffnessEndothelial dysfunctionCancer patientsHuman epidermal growth factor receptor-2 (HER2) positive early breast cancerPositive early breast cancerSignificant cardiovascular risk factorsCardiovascular risk factorsInitiation of chemotherapyAddition of trastuzumabEarly breast cancerCase-control studyTrastuzumab treatmentRisk factorsChemotherapyControl groupConsiderable impairmentPatientsCancerTrastuzumab